Intended for healthcare professionals

  1. Research
  2. Derivation and...
  3. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Research

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39261.471806.55 (Published 19 July 2007) Cite this as: BMJ 2007;335:136

Related articles

See more

Cited by...

  • Educational inequalities in statin treatment for preventing cardiovascular disease: cross-sectional analysis of UK Biobank
  • Performing risk stratification for COVID-19 when individual level data is not available - the experience of a large healthcare organization
  • GPs familiarity with and use of cardiovascular clinical prediction rules: a UK survey study
  • Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care
  • Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study
  • Metabolic dysregulation of the lysophospholipid/autotaxin axis in the chromosome 9p21 gene SNP rs10757274
  • Prediction performance of a cardiovascular risk assessment tool using Stanford EHR data repository
  • Development and validation of prediction models to estimate risk of primary total hip and knee replacements using data from the UK: two prospective open cohorts using the UK Clinical Practice Research Datalink
  • Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation
  • Performance of a Framingham cardiovascular risk model among Indians and Europeans in New Zealand and the role of body mass index and social deprivation
  • Does bone mineral density improve the predictive accuracy of fracture risk assessment? A prospective cohort study in Northern Denmark
  • Managing dyslipidaemia for the primary prevention of cardiovascular disease
  • Can doctors and patients correctly estimate cardiovascular risk? A cross-sectional study in primary care
  • Incremental Value of Repeated Risk Factor Measurements for Cardiovascular Disease Prediction in Middle-Aged Korean Adults: Results From the NHIS-HEALS (National Health Insurance System-National Health Screening Cohort)
  • Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention?
  • Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
  • Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status
  • Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
  • Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care
  • Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
  • Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol
  • Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)
  • Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
  • Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated: Con Side of the Argument
  • GPs' perspectives on managing the NHS Health Check in primary care: a qualitative evaluation of implementation in one area of England
  • Prediction models for cardiovascular disease risk in the general population: systematic review
  • Distribution of lifespan gain from primary prevention intervention
  • Perspectives in Primary Care: A Conceptual Framework and Path for Integrating Social Determinants of Health Into Primary Care Practice
  • Association Between a Healthy Heart Score and the Development of Clinical Cardiovascular Risk Factors Among Women: Potential Role for Primordial Prevention
  • High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure: Potential Role of {beta}-Blockers to Reduce Their Elevated Risk
  • Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review
  • How Does Cardiovascular Disease First Present in Women and Men?: Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People
  • How to develop a more accurate risk prediction model when there are few events
  • Twenty top papers--the ones that got away and the results of the top six poll
  • Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research
  • Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study
  • Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study
  • The evidence base for fat guidelines: a balanced diet
  • Lifestyle-Based Prediction Model for the Prevention of CVD: The Healthy Heart Score
  • Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data
  • Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
  • Survival analysis in hematologic malignancies: recommendations for clinicians
  • The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study
  • The impact of NHS Health Checks on the prevalence of disease in general practices: a controlled study
  • Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  • Patient-Accessible Tool for Shared Decision Making in Cardiovascular Primary Prevention: Balancing Longevity Benefits Against Medication Disutility
  • A coronary heart disease prediction model: the Korean Heart Study
  • Pre-Eclampsia and Future Cardiovascular Risk Among Women: A Review
  • Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study
  • Clinical prediction rules in practice: review of clinical guidelines and survey of GPs
  • Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited)
  • A New Approach to Residual Risk in Treated Hypertension--3P Screening
  • Cardiovascular risk scores: qualitative study of how primary care practitioners understand and use them
  • Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study
  • Clinical Scores for Predicting Recurrence After Transient Ischemic Attack or Stroke: How Good are They?
  • Cardiovascular Risk Management After a Hypertensive Disorder of Pregnancy
  • Interplay of Coronary Artery Calcification and Traditional Risk Factors for the Prediction of All-Cause Mortality in Asymptomatic Individuals
  • Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Association Between Family History and Coronary Heart Disease Death Across Long-Term Follow-Up in Men: The Cooper Center Longitudinal Study
  • Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2
  • Cardiovascular risk age: concepts and practicalities
  • Comparisons of established risk prediction models for cardiovascular disease: systematic review
  • Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study
  • Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results)
  • Original and REGICOR Framingham Functions in a Nondiabetic Population of a Spanish Health Care Center: A Validation Study
  • Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study
  • Relative Familial Clustering of Cerebral Versus Coronary Ischemic Events
  • A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT)
  • Development of a Cardiovascular Risk Score for Use in Low- and Middle-Income Countries
  • ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
  • ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension
  • Cardiovascular risk scores do not account for the effect of treatment: a review
  • Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women--2011 Update: A Guideline From the American Heart Association
  • Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women--2011 Update: A Guideline From the American Heart Association
  • Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice
  • The Authors' reply
  • Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose
  • Advantages of QRISK2 (2010): the key issue is ethnicity and extent of reallocation
  • Familial History of Stroke Is Associated With Acute Coronary Syndromes in Women
  • Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study
  • Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database
  • Primary care research and clinical practice: cardiovascular disease
  • Genetic Cardiovascular Risk Prediction: Will We Get There?
  • Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis: The Heinz Nixdorf Recall Study
  • Development and Validation of Risk Adjustment Models for Long-Term Mortality and Myocardial Infarction Following Percutaneous Coronary Interventions
Back to top